The Developmental Research Program of the University of Pittsburgh Cancer Institute Lung Cancer SPOREwill be carried out for the purpose of identifying and facilitating innovative new pilot projects in lung cancerresearch. The overall goal of the Developmental Research Program is to provide seed funding toinvestigators for novel research in lung cancer to further the basic, clinical and translational researchpriorities of the Lung Cancer SPORE. The specific goals of this Program are : 1) to provide seed fundingopportunities for initial investigation of promising novel research in lung cancer: 2) to stimulate basic, clinical,and translational lung cancer research in areas of high priority to the Lung Cancer SPORE; 3) to facilitatedevelopment of pilot projects into full project status in the Lung Cancer SPORE or to be competitive forindependent investigator-initiated proposals to other funding agencies; and 4) to increase the visibility ofLung Cancer SPORE activities and increase participation among the institution's clinicians and researchers.Our design for the Developmental Research Program in the renewal is similar to the process used during thefirst grant period. Drs. William L. Bigbee and Joel S. Greenberger will provide Program leadership for basicand clinical research, respectively. The Developmental Research Program will utilize institutional web-basedresources and printed announcements to notify the research community at the UPCI, the University ofPittsburgh Medical Center (UPMC), and the affiliated Carnegie Mellon University of the availability ofresearch funds to support pilot projects in lung cancer. In response to the new SPORE guidelineencouraging inter-institutional collaboration, we will also make the program available to our sister CancerCenters in Philadelphia, who are part of the statewide Pennsylvania Cancer Control Consortium (PAC-3)initiative. A standing Developmental Research Program Committee, together with ad hoc reviewers withspecific expertise as needed drawn from the UPCI, UPMC, the Lung Cancer SPORE External AdvisoryBoard, or other SPOREs will provide rigorous and consistent peer review of the solicited project proposals.The proposed Developmental Research Program budget will include $70,000 per year in funds from the NCIthrough this proposal, together with an additional $50,000 per year in matching funds from the UPCI.Proposals will be solicited and reviewed on an annual basis and grants of $30,000-$50,000 per year for 1-2years will be awarded to the most meritorious proposals. These activities of the Developmental ResearchProgram will stimulate innovative research toward meeting the translations goals of the Lung CancerSPORE: reduction in the incidence, morbidity, and mortality from lung cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA090440-06
Application #
7088510
Study Section
Special Emphasis Panel (ZCA1-GRB-I (J1))
Project Start
2006-05-01
Project End
2011-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
6
Fiscal Year
2006
Total Cost
$70,000
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Leng, Shuguang; Diergaarde, Brenda; Picchi, Maria A et al. (2018) Gene Promoter Hypermethylation Detected in Sputum Predicts FEV1 Decline and All-Cause Mortality in Smokers. Am J Respir Crit Care Med 198:187-196
Rothenberger, Natalie J; Somasundaram, Ashwin; Stabile, Laura P (2018) The Role of the Estrogen Pathway in the Tumor Microenvironment. Int J Mol Sci 19:
Yochum, Zachary A; Cades, Jessica; Wang, Hailun et al. (2018) Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene :
Stabile, Laura P; Farooqui, Mariya; Kanterewicz, Beatriz et al. (2018) Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. J Thorac Oncol 13:399-412
Volonte, Daniela; Vyas, Avani R; Chen, Chen et al. (2018) Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence. J Biol Chem 293:1794-1809
Yochum, Zachary A; Cades, Jessica; Mazzacurati, Lucia et al. (2017) A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer. Mol Cancer Res 15:1764-1776
Chatterjee, Suman; Huang, Eric H-B; Christie, Ian et al. (2017) Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS-Mutant NSCLC Is Mediated via Reactivation of the ERK-p90RSK-mTOR Signaling Network. Mol Cancer Ther 16:793-804
Moiseeva, Tatiana; Hood, Brian; Schamus, Sandy et al. (2017) ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1. Nat Commun 8:1392
Sun, Fan; Xiao, Gutian; Qu, Zhaoxia (2017) Murine Bronchoalveolar Lavage. Bio Protoc 7:
Zhou, Jingjiao; Qu, Zhaoxia; Sun, Fan et al. (2017) Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation. Cancer Immunol Res 5:257-268

Showing the most recent 10 out of 191 publications